Skip to content

Novel Equations for Estimating Lean Body Mass in Patients With Chronic Kidney Disease

Novel Equations for Estimating Lean Body Mass in Patients With Chronic Kidney Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04074278
Enrollment
300
Registered
2019-08-30
Start date
2013-03-01
Completion date
2015-12-01
Last updated
2019-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases, Lean Body Mass

Keywords

mid-arm muscle circumference, handgrip strength, dual-energy x-ray absorptiometry

Brief summary

Simplified methods to estimate lean body mass (LBM), an important nutritional measure representing muscle mass and somatic protein, are lacking in non-dialyzed patients with chronic kidney disease (CKD). Objective: We developed and tested a reliable equations for estimation of LBM in daily clinical practice.

Detailed description

Two cross-sectional data sets were derived from outpatients with CKD stage 3-5 in Peking University First Hospital.Two equations for estimating LBM based on midarm muscle circumference (MAMC) or hand grip strength (HGS)were developed and validated in CKD patients with dual-energy x-ray absorptiometry (DEXA) as referenced gold method. Demographic data, comorbidity, and other clinical variables were also recorded.

Interventions

None listed

Sponsors

Peking University First Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* non-dialyzed patients with CKD stage 3-5 * clinical stable * a willingness to be examined with all measurements being taken simultaneously.

Exclusion criteria

* systemic infections, acute cardiovascular events, operations, trauma, active hepatitis or tumor * severe edema within one month prior to the study * chronic infections, connective tissue disease, hyper- or hypothyroidism, amputations or pregnancy, * taking immunosuppressive agents and anti-inflammatory medication chronically

Design outcomes

Primary

MeasureTime frameDescription
LBM_DEXAbetween March 1st, 2014 and December 1st, 2015lean body mass measured by dual-energy x-ray absorptiometry (DEXA)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026